How big is the New Zealand Self-Monitoring Blood Glucose Market?

The New Zealand Self-Monitoring Blood Glucose Market size is expected to reach USD 152.68 million in 2024 and grow at a CAGR of 5.20% to reach USD 196.72 million by 2029. Read More

What is the current New Zealand Self-Monitoring Blood Glucose Market size?

In 2024, the New Zealand Self-Monitoring Blood Glucose Market size is expected to reach USD 152.68 million. Read More

Who are the key players in New Zealand Self-Monitoring Blood Glucose Market?

Abbott Diabetes Care, Roche Diabetes Care, LifeScan Inc., Ascensia Diabetes Care and i-SENS, Inc. are the major companies operating in the New Zealand Self-Monitoring Blood Glucose Market. Read More

What years does this New Zealand Self-Monitoring Blood Glucose Market cover, and what was the market size in 2023?

In 2023, the New Zealand Self-Monitoring Blood Glucose Market size was estimated at USD 145.13 million. The report covers the New Zealand Self-Monitoring Blood Glucose Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the New Zealand Self-Monitoring Blood Glucose Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

New Zealand Self-Monitoring Blood Glucose Market Share

Statistics for the 2023 & 2024 New Zealand Self-Monitoring Blood Glucose market share, created by Mordor Intelligence™ Industry Reports. New Zealand Self-Monitoring Blood Glucose share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of New Zealand Self-Monitoring Blood Glucose Industry

New Zealand self-monitoring blood glucose market is moderately fragmented, with a few significant and other generic players. Manufacturers like i-Sens, Abbott, LifeScan, and Ascensia occupy a major share.